Author

Sara Zemiti

InsermORCID 0009-0008-7141-8398Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1 Organism:zebrafish· 1

Frequent Co-Authors

Delphine GitenayiD· 2 shared Guillaume BossisiD· 2 shared Loïs CoënoniD· 2 shared Marion de ToledoiD· 2 shared Martín VillalbaiD· 2 shared Alberto AneliD· 1 shared Amel Bouzid· 1 shared Ana Bellia Aznar· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Delphine GitenayORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 26, 2025

Metabolic rewiring of cancer cells induces metastasis via ERK5 but triggers recognition by NK cells

Sara Zemiti, Steffy Escayg, Benjamin Hay…·Delphine Gitenay

This study shows that metabolic rewiring via fatty acid oxidation promotes cancer metastasis but also enhances NK cell recognition and killing of metastatic cells.

1 citation

mousezebrafish

𝕏 PostBluesky

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedJul 15, 2025

The SUMOylation inhibitor TAK-981 (Subasumstat) triggers IFN-I-dependent activation of Natural Killer cells against Acute Myeloid Leukemias.

Rawan Hallal, Marion de Toledo, Denis Tempé…·Guillaume Bossis

This paper shows that TAK-981 activates NK cells against AML by inducing IFN-I secretion, enhancing their cytotoxicity and cytokine production.

5 citations

humanexperimental assay

𝕏 PostBluesky